Skip to main content
Article thumbnail
Location of Repository

Emerging quinolones resistant transfer genes among gram-negative bacteria, isolated from faeces of HIV/AIDS patients attending some Clinics and Hospitals in the City of Benin, Edo State, Nigeria

By Enabulele I O, Yah S C, Yusuf E O and Eghafona N O


A survey of 1431 gram-negative bacilli from June 2001 to September 2005 were obtained from the faeces of 920 HIV/AIDS patients attending some Clinics and Hospitals in Benin City, Nigeria, were screened for quinolones resistance gene. The HIV/AIDS patients CD4 cells range was ≤14/mm3 ≥800/mm3 of blood. Out of the 1431 isolates, 343 (23.9%) were resistance to quinolones with a MIC ≥4μg/ml for norfloxacin, ciprofloxacin and pefloxacin while a MIC of ≥32 µg/ml for nalidixic acid. The screened isolates include Pseudomonas aeruginosa 64(18.7%), E coli 92(26.8%), Klebsiella pneumoniae 53(15.4%), Salmonella typhi 39(11.4%), Shigella dysenteriae 36(10.5%), Proteus mirabilis 34(9.9%) and Serratia marcescens 25(7.3%). The average resistance of the isolates to the various quinolones ranged from 42.7% to 66.7%. Klebsiella were the most resistant isolates with a mean resistance of 66.7% while Proteus were the less resistant isolates with a mean resistance of 42.7%. Most isolates were resistant to Nalidixic acid followed by norfloxacin while the less resistant were to the pefloxacin. The frequency of qnr genes transfer to EJRifr as recipient ranged from 2 x 10-2 to 6 x 10-6 with an average of 2 plasmids per cell. The molecular weight of the plasmids ranged from <2.9kbp to <5.5 kbp. This indicated that plasmids allowed the movement of genetic materials including qnr resistant genes between bacteria species and genera in Benin City, Nigeri

Topics: Online Journal of Health and Allied Sciences
Publisher: Dr. B.S. Kakkilaya
Year: 2006
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles


    1. (2004). 4th Edition.
    2. (1997). Antibiotics susceptibility testing by a standardized single disk method.
    3. (1995). Antimicrobial susceptibility trends among Escherichia coli and Shigella species isolated from rural Egyptian Paediatroc population with diarrhoea between
    4. Bacterial Infections. In:
    5. (1998). Clinical management of HIV/AIDS.
    6. District Laboratory Practice Manual in Tropical Countries. Part 2.
    7. Emerging Plasmid-Mediated Quinolone Resistance Associated with the qnr Gene in Klebsiella pneumoniae Clinical Isolates in the United States. Antimicrob Agents Chemother.
    8. Epidemiology of HIV/AIDS in Nigeria.
    9. (2000). for clinical laboratory standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow aerobically. 5th Edition. Approved Standard
    10. gyra mutations in ciprofloxacinresistant clinical isolates of Pseudomonas aeruginosa in a Silesian hospital in Poland.
    11. (2001). HIV/AIDS and poverty.
    12. (1988). Infections due to encapsulated bacteria, Salmonella, Shigella and Campylobacter. Infect Dis Clin North Am.
    13. Information 199. Essential Drugs Guidelines for Antimicrobial Susceptibility Testing.
    14. Invasive Bacterial Infections in Children with HIV Infection. In: Pizzo PA, Wilfert CM, Eds. Pediatric AIDS.
    15. Keynote address on HIV/AIDS crisis in Sub- Saharan Africa.
    16. Manual for the identification of medical bacteriology.
    17. Microbial threats to health: emergence, detection, and response.
    18. Organization (WHO). Deaths by cause, sex and mortality stratum in WHO Regions,
    19. Prevention of infectious complications of paediatric HIV infection in Africa.
    20. Therapeutic challenges posed by bacterial bioterrorism threats.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.